IND-ENABLING STUDIES TO REPURPOSE CD19-TAC T CELLS (TAC01-CD19) FOR TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

Triumvira Immunologics Usa Inc

Investigators